Veraxa Biotech Holding AG (VRXA) Cash & Current Investments (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Cash & Current Investments for 2 consecutive years, with $1.5 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Cash & Current Investments fell 75.91% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (down 75.91% YoY), and the FY2025 full-year result was $1.5 million, down 75.91% from the prior year.
• Cash & Current Investments eased to $1.5 million in Q4 2025 per VRXA's latest filing, from $6.3 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $6.3 million in Q4 2024 to a low of $1.5 million in Q4 2025.